Skip to main content
Top
Published in: Digestive Diseases and Sciences 1/2011

01-01-2011 | Original Article

Schistosoma mansoni Infection but Not Egg Antigen Promotes Recovery from Colitis in Outbred NMRI Mice

Authors: Peggy Bodammer, Grit Waitz, Micha Loebermann, Martha Charlotte Holtfreter, Claudia Maletzki, Marzena Renata Krueger, Horst Nizze, Joerg Emmrich, Emil Christian Reisinger

Published in: Digestive Diseases and Sciences | Issue 1/2011

Login to get access

Abstract

Background

The ability of intestinal helminths to manipulate the immune system of their host towards a Th2 response has been proposed to modulate auto-immune and allergic diseases.

Aims

This initial study investigated the anti-inflammatory potential of S. mansoni and soluble egg antigen (SEA) in a murine model of colitis.

Methods

Colitis was induced in female NMRI mice by 5% dextran sulfate sodium (DSS) for 7 days, either 9 weeks post-infection with S. mansoni or during treatment with SEA. In addition to clinical signs of colitis, colon histology, immunohistochemistry, and flow cytometry of leukocytes were performed. Colon cytokines were measured using a quantitative real-time technique.

Results

Infection with cercariae of S. mansoni attenuated DSS-induced colitis. Clinical symptoms such as weight loss and shortening of colon length were significantly prevented. Histological scores and cell infiltration were affected and expression of pro-inflammatory cytokines in the colons of infected DSS colitis mice was reduced. In contrast, application of SEA failed to improve colitis, even though some findings like earlier manifestation of inflammation and local induction of Th2 cytokines were similar to the effects of cercarial infection.

Conclusions

The results presented here suggest that SEA treatment could not protect mice from acute colitis. However, both infection with S. mansoni and injection of SEA affect mucosal immune responses.
Literature
1.
go back to reference Sood A, Midha V. Epidemiology of inflammatory bowel disease in Asia. Indian J Gastroenterol. 2007;26:285–289.PubMed Sood A, Midha V. Epidemiology of inflammatory bowel disease in Asia. Indian J Gastroenterol. 2007;26:285–289.PubMed
3.
go back to reference Kitagaki K, Businga TR, Racila D, et al. Intestinal helminths protect in a murine model of asthma. J Immunol. 2006;177:1628–1635.PubMed Kitagaki K, Businga TR, Racila D, et al. Intestinal helminths protect in a murine model of asthma. J Immunol. 2006;177:1628–1635.PubMed
5.
go back to reference Araújo MI, Hoppe BS, Medeiros M, et al. Schistosoma mansoni infection modulates the immune response against allergic and auto-immune disease. Mem Inst Oswaldo Cruz. 2004;99:27–32.PubMed Araújo MI, Hoppe BS, Medeiros M, et al. Schistosoma mansoni infection modulates the immune response against allergic and auto-immune disease. Mem Inst Oswaldo Cruz. 2004;99:27–32.PubMed
6.
go back to reference Setiawan T, Metwali A, Blum AM, et al. Heligmosomoides polygyrus promotes regulatory T-cell cytokine production in the murine distal intestine. Infect Immun. 2007;75:4655–4663.CrossRefPubMed Setiawan T, Metwali A, Blum AM, et al. Heligmosomoides polygyrus promotes regulatory T-cell cytokine production in the murine distal intestine. Infect Immun. 2007;75:4655–4663.CrossRefPubMed
7.
go back to reference Hunter MM, Wang A, Hirota CL, et al. Neutralizing anti-IL-10 antibody blocks the protective effect of tapeworm infection in am murine model of chemically induced colitis. J Immunol. 2005;174:7368–7375.PubMed Hunter MM, Wang A, Hirota CL, et al. Neutralizing anti-IL-10 antibody blocks the protective effect of tapeworm infection in am murine model of chemically induced colitis. J Immunol. 2005;174:7368–7375.PubMed
8.
go back to reference Khan WI, Blennerhasset PA, Varghese AK, et al. Intestinal nematode infection ameliorates experimental colitis in mice. Infect Immun. 2002;70:5931–5937.CrossRefPubMed Khan WI, Blennerhasset PA, Varghese AK, et al. Intestinal nematode infection ameliorates experimental colitis in mice. Infect Immun. 2002;70:5931–5937.CrossRefPubMed
9.
go back to reference Moreels TG, Nieuwendijk RJ, De Man JG, et al. Concurrent infection with Schistosoma mansoni attenuates inflammation induced changes in colonic morphology, cytokine levels, and smooth muscle contractility of trinitrobenzene sulphonic acid induced colitis in rats. Gut. 2004;53:99–107.CrossRefPubMed Moreels TG, Nieuwendijk RJ, De Man JG, et al. Concurrent infection with Schistosoma mansoni attenuates inflammation induced changes in colonic morphology, cytokine levels, and smooth muscle contractility of trinitrobenzene sulphonic acid induced colitis in rats. Gut. 2004;53:99–107.CrossRefPubMed
10.
go back to reference Elliott DE, Li J, Blum A, et al. Exposure to schistosome eggs protects mice from TNBS-induced colitis. Am J Physiol Gastrointest Liver Physiol. 2003;284:385–391. Elliott DE, Li J, Blum A, et al. Exposure to schistosome eggs protects mice from TNBS-induced colitis. Am J Physiol Gastrointest Liver Physiol. 2003;284:385–391.
11.
go back to reference Mo HM, Liu WQ, Lei JH, et al. Schistosoma japonicum eggs modulate the activity of CD4 + CD25 + Tregs and prevent development of colitis in mice. Exp Parasitol. 2007;116:385–389.CrossRefPubMed Mo HM, Liu WQ, Lei JH, et al. Schistosoma japonicum eggs modulate the activity of CD4 + CD25 + Tregs and prevent development of colitis in mice. Exp Parasitol. 2007;116:385–389.CrossRefPubMed
12.
go back to reference Summers RW, Elliott DE, Qadir K, et al. Trichuris suis seems to be safe and possible effective in the treatment of inflammatory bowel disease. Am J Gastroenterol. 2003;98:2034–2041.CrossRefPubMed Summers RW, Elliott DE, Qadir K, et al. Trichuris suis seems to be safe and possible effective in the treatment of inflammatory bowel disease. Am J Gastroenterol. 2003;98:2034–2041.CrossRefPubMed
13.
go back to reference Summers RW, Elliott DE, Urban JF, et al. Trichuris suis therapy for active ulcerative colitis: a randomized controlled trial. Gastroenterology. 2005;128:825–832.CrossRefPubMed Summers RW, Elliott DE, Urban JF, et al. Trichuris suis therapy for active ulcerative colitis: a randomized controlled trial. Gastroenterology. 2005;128:825–832.CrossRefPubMed
14.
go back to reference Summers RW, Elliott DE, Urban JF, et al. Trichuris suis therapy in Crohn′s disease. Gut. 2005;54:87–90.CrossRefPubMed Summers RW, Elliott DE, Urban JF, et al. Trichuris suis therapy in Crohn′s disease. Gut. 2005;54:87–90.CrossRefPubMed
15.
go back to reference Kradin RL, Badizadegan K, Auluck P, et al. Iatrogenic Trichuris suis infection in a patient with Crohn disease. Arch Pathol Lab Med. 2006;130:718–720.PubMed Kradin RL, Badizadegan K, Auluck P, et al. Iatrogenic Trichuris suis infection in a patient with Crohn disease. Arch Pathol Lab Med. 2006;130:718–720.PubMed
16.
go back to reference Smith P, Mangan NE, Walsh CM, et al. Infection with a helminth parasite prevents experimental colitis via a macrophage-mediated mechanism. J Immunol. 2007;178:4557–4566.PubMed Smith P, Mangan NE, Walsh CM, et al. Infection with a helminth parasite prevents experimental colitis via a macrophage-mediated mechanism. J Immunol. 2007;178:4557–4566.PubMed
17.
go back to reference Okayasu I, Hatakeyama S, Yamada M, et al. A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology. 1990;98:694–702.PubMed Okayasu I, Hatakeyama S, Yamada M, et al. A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology. 1990;98:694–702.PubMed
18.
go back to reference Kawada M, Arihiro A, Mizoguchi E. Insights from advances in research of chemically induced experimental models of human inflammatory bowel disease. World J Gastroenteol. 2007;13:5581–5593. Kawada M, Arihiro A, Mizoguchi E. Insights from advances in research of chemically induced experimental models of human inflammatory bowel disease. World J Gastroenteol. 2007;13:5581–5593.
19.
go back to reference Melgar S, Karlsson L, Rehnström E, et al. Validation of murine dextran sulfate sodium-induced colitis using four therapeutic agents for human inflammatory bowel disease. Int Immunopharmacol. 2008;8:836–844.CrossRefPubMed Melgar S, Karlsson L, Rehnström E, et al. Validation of murine dextran sulfate sodium-induced colitis using four therapeutic agents for human inflammatory bowel disease. Int Immunopharmacol. 2008;8:836–844.CrossRefPubMed
20.
go back to reference Wirtz S, Neufert C, Weigmann B, et al. Chemically induced mouse models of intestinal inflammation. Nat Protoc. 2007;2:541–546.CrossRefPubMed Wirtz S, Neufert C, Weigmann B, et al. Chemically induced mouse models of intestinal inflammation. Nat Protoc. 2007;2:541–546.CrossRefPubMed
21.
go back to reference Cruickshank SM, English NR, Felsburg PJ, et al. Characterization of colonic dendritic cells in normal and colitic mice. World J Gastroenterol. 2005;11:6338–6347.PubMed Cruickshank SM, English NR, Felsburg PJ, et al. Characterization of colonic dendritic cells in normal and colitic mice. World J Gastroenterol. 2005;11:6338–6347.PubMed
22.
go back to reference Maul J, Loddenkemper C, Mundt P, et al. Peripheral and intestinal regulatory CD4 + CD25 (high) T-cells in inflammatory bowel diseases. Gastroenterology. 2005;128:1868–1878.CrossRefPubMed Maul J, Loddenkemper C, Mundt P, et al. Peripheral and intestinal regulatory CD4 + CD25 (high) T-cells in inflammatory bowel diseases. Gastroenterology. 2005;128:1868–1878.CrossRefPubMed
23.
go back to reference Pearce EJ, Kane CM, Sun J, et al. Th2 response polarization during infection with the helminth parasite Schistosoma mansoni. Immunol Rev. 2004;201:117–126.CrossRefPubMed Pearce EJ, Kane CM, Sun J, et al. Th2 response polarization during infection with the helminth parasite Schistosoma mansoni. Immunol Rev. 2004;201:117–126.CrossRefPubMed
24.
go back to reference Ashton PD, Harrop R, Shah B, et al. The schistosome egg development and secretions. Parasitology. 2001;122:329–338.CrossRefPubMed Ashton PD, Harrop R, Shah B, et al. The schistosome egg development and secretions. Parasitology. 2001;122:329–338.CrossRefPubMed
25.
go back to reference Ruyssers NE, De Winter BY, De Man JG, et al. Therapeutic potential of helminth soluble proteins in TNBS-induced colitis in mice. Inflamm Bowel Dis. 2009;15:491–500.CrossRefPubMed Ruyssers NE, De Winter BY, De Man JG, et al. Therapeutic potential of helminth soluble proteins in TNBS-induced colitis in mice. Inflamm Bowel Dis. 2009;15:491–500.CrossRefPubMed
Metadata
Title
Schistosoma mansoni Infection but Not Egg Antigen Promotes Recovery from Colitis in Outbred NMRI Mice
Authors
Peggy Bodammer
Grit Waitz
Micha Loebermann
Martha Charlotte Holtfreter
Claudia Maletzki
Marzena Renata Krueger
Horst Nizze
Joerg Emmrich
Emil Christian Reisinger
Publication date
01-01-2011
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 1/2011
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-010-1237-y

Other articles of this Issue 1/2011

Digestive Diseases and Sciences 1/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.